OneMedNet announces board member change to drive post-IPO growth

MINNEAPOLIS, Oct. 2, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a leading curator of regulatory Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to listed company. This move reinforces our commitment to dynamic leadership and active engagement in accelerating growth in this new phase.

We express our heartfelt thanks Paul CaseyAND Erkan Akyuz for their invaluable contribution at a key moment in our company’s history. Their leadership and guidance were instrumental in bringing our IPO to fruition, laying a solid foundation for OneMedNet’s entry into the public markets. We thank them for their service and wish them all the best in their future endeavors.

In line with our vision for the future, we are happy to welcome two outstanding people to our Management Board.

Jair Clarkehe currently serves as executive advisor to the CEO at World Wide Technology (WWT), serves as CEO at Laigic, and is a member of the board of directors of Xponential (NYSE:XPOF), which focuses on health and wellness. His career also includes serving as Global CTO at Microsoft, where he played a key role in shaping the company’s technology direction. He previously led Disney’s Big Data, Technology Strategy and Digital Intelligence practice and co-led IBM Watson strategy and delivery.

Jair’s experience allows him to contribute to the following business priorities:

• Market expansion and business development: It leverages its extensive network and expertise in artificial intelligence and digital intelligence to explore new markets and establish strategic partnerships.
• Technology platform improvement: Leveraging their expertise from Microsoft, Disney and IBM Watson to enhance OneMedNet’s technology solutions.
• Operational performance: Focusing on greater efficiency and scalability.

Sherry Coonse McCrawcurrently vice president of human resources and former chief financial officer of BMW North America, he has a diverse background in both finance and human capital strategy. As the new chair of our audit committee, her expertise will be key in:

• Financial supervision: Ensuring sound financial management and strategic planning.
• Transparency and accountability: Maintaining integrity and trust as we scale our business.
• Human Resources Leadership: He combines his HR and financial experience to align human capital strategies with organizational goals.

“OneMedNet is at an exciting time, and the addition of Sherry and Jair to our board is a testament to our commitment to excellence and innovation,” he said Jeffrey Yu, MD, founder and president of OneMedNet. “We are grateful for Paul and Erkan’s foundational work, and with Sherry and Jair on board, we are well-positioned to take our company to new heights.”

This transition reflects our strategic focus on improving corporate governance, leveraging diverse expertise and ensuring that our Board is prepared to lead OneMedNet through its next phase of growth and innovation.

About OneMedNet Corporation

OneMedNet delivers innovative solutions that unlock the significant value contained in the real-world data (“RWD”) repositories of the more than 1,400 health systems and provider sites that currently make up the iRWD network. OneMedNet’s patented iRWD platform provides secure, end-to-end management of diverse types of clinical data, including electronic health records, laboratory test results and, in particular, medical imaging. Using the robust iRWD platform, the company securely deidentifies, searches and manages clinical data using a wealth of internal and external research. opportunities for its customers developing artificial intelligence in medicines, medical devices and imaging/diagnostics.

The OneMedNet platform is designed to meet the clinical requirements needed in a variety of fields including, but not limited to, rare diseases, oncology and cardiology. The company is committed to providing accurate and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to improve patient outcomes and help pave the next wave of healthcare innovation. More information can be found at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make oral or written forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from information currently available to us. Such forward-looking statements address future events or our future performance, including: our financial results and projections; our revenue and profit growth; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may”, “should”, “expects”, “anticipates”, “considers”, “estimates”, “believes” , “plans”, “anticipated”, “predictions”, “potential” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technologies and changing market needs; and competitive environment of our operations. These and other factors could cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made by us or our representatives from time to time may not occur and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statements, regardless of whether, as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives may not occur.

OneMedNet contacts:

Michael Wong, Chief Marketing Officer

Phone: 800.918.7189

E-mail: (email protected)

SOURCE: ONEMEDNET CORPORATION